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Adjacent to the major histocompatibility complex (MHC) genes of the mouse lies 
a  series of genes which code for T-lymphocyte surface antigens. The Tla genes were 
the first to be described a  decade ago  (1).  The antigen(s)  governed by this locus is 
expressed exclusively on thymocytes and leukemia cells and thus represented the first 
example for an alloantigen characteristic of a  differentiated cell type. Many other 
differentiation antigens have since been discovered, but no other linkage group than 
the IXth has shown an equal concentration of genes specifying cell surface antigens. 
Some of these antigens such as H-2K and H-2D are expressed on most tissues, whereas 
others display a more restricted tissue distribution. Thus, Ia determinants specified by 
the  I-A  and  I-E  subregion  are  predominantly  expressed  on  B  lymphoeytes  and 
macrophages  (2),  whereas  the  region  between  H-2D  and  Tla  codes  for  a  set  of 
serologically defined  antigens,  termed  Qa  antigens,  of which  the  Qa-2  and  Qa-3 
antigens are predominantly found on T lymphocytes of different differentiation stages 
(3-5). In addition, a set of surface structures encoded by the Tla region was recently 
identified by the use of cytotoxic T  cells (6,  7, and K. F. Lindahl, personal commu- 
nication). 
We report here two new surface antigens ofT lymphocytes, Qat-4 and Qat-5, which 
are  governed  by  genes  linked  to  the  Tla/Qa  region.  The  identification  of these 
differentiation  antigens  was  made  possible  by  the  discovery  of two  monoclonal 
antibodies  which  arose  in  hybridomas  generated  by cell  fusion  between  BALB/c 
myeloma cells and AKR'spleen cells, immune to C57BL/6 lymphocytes. This report 
is an example of the value of monoclonal antibodies for the detection of new antigenic 
systems, a feature which has been stressed repeatedly since introduction of the fusion 
technique by K6hler and Milstein (8). 
Materials and Methods 
Mice. Mice were purchased from G1. Bomholtgaard, Ltd., Ry, Denmark; OLAC 1976 Ltd., 
England;  The Jackson  Laboratory, Bar  Harbor,  Maine;  or were  maintained  in  our own 
facilities. 
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Cell Hybridization. The cell hybridization technique for the production of hybridomas secreting 
alloantibodies has been described in detail elsewhere  (8, 9). In the present case, four female 
AK_R mice were immunized  intravenously with  a  mixture of 2  ×  10  v spleen and  thymus 
cells of male C57BL/6 mice. After 3 wk the mice received an additional injection of 3  ×  107 
spleen cells  and  3  ×  107  thymocytes. 3  d  later the  spleen cells  were  hybridized with  the 
myeloma P3-NS-I-Ag4 (a gift of Dr. C. Milstein, Cambridge University) with polyethylene 
glycol, mol wt 4,000. The fusion mixture was distributed at a density of 5 ×  105 cells per well 
into 624 cups of Costar 3524 multiwell plates (Costar,  Data Packaging, Cambridge, Mass.). 
Growth of hybrid cells was observed in 308 wells. 
Culture supernates were tested for alloantibody activity in a microcytotoxicity assay (9) with 
C57BL/6 spleen cells as target cells. 
Cloning of hybridoma cells from wells displaying cytotoxic activity was performed by the 
limiting dilution technique (10). For further analysis,  either culture supernates of cloned cells 
were used, or high titered ascites fluids were obtained by intraperitoneal injection of hybridoma 
cells into either (AKR ×  DBA/2)F1  or NMRI nu/nu mice which 2 d previously had received 
0.5 ml mineral oil intraperitoneally (11). 
Serological Methods. Serological  analysis of monoelonal antibodies was performed utilizing the 
microeytotoxicity assay (9) as well as the chromium release assay (3). For indirect immunoflu- 
orescence,  cells  were  first  incubated  with  monoclonal  antibodies  for  30  min  at  4°C  and 
subsequently, after washing, with fluorescein-conjugated rabbit anti-mouse Ig (Behringwerke, 
Marburg/Lahn, Federal Republic of Germany) for another 30 min at 4°C. Fluorescence  was 
evaluated with a fluorescence  microscope (Leitz, Wetzlar, Federal Republic of Germany) and 
with a fluorescence-activated cell sorter (FACS I, Becton, Dickinson  FACS Systems, Mountain 
View, Calif.).  Removal of B lymphocytes was performed by either nylon wool fractionation 
(12) or by use of anti-mouse-Ig-coated plastic dishes  (13). 
Results 
The spleen cells of two AKR mice immune to C57BL/6 lymphocytes were hybrid- 
ized with the myeloma P3-NS-1-Ag4. Of 624 wells, each seeded with 5  ×  l0  s cells, 
308 showed growth, and two wells, numbers B 16-146 and B 16-167, contained cytotoxic 
antibody for C57BL/6 spleen cells. Hybridoma cells from these wells were cloned by 
the limiting dilution technique. Because all subclones isolated were antibody positive, 
the original wells contained most likely single, stable clones. Both hybridomas were 
adapted  to  growth  in  ascitic  form in  either  (AKR  ×  DBA/2)F1  or NMRI  nu/nu 
mice which  had received 0.5  ml mineral oil  2  d  previously. Precipitation  of ascitic 
fluid by ammonium sulfate yielded  14 mg/ml of immunoglobulin for B16-146  and 
6.5  mg/ml  for B16-167.  Fig.  1 shows  the  cytotoxicity titers  of ascites  and  culture 
supernates.  Accordingly,  ascites  fluids  (Fig.  1A)  contain  100-  to  1,000-fold  higher 
antibody concentrations than culture supernates (Fig.  1 B). Culture supernates of both 
hybridomas contain immunoglobulins consisting of #-heavy and kappa light chains, 
as determined by reaction with class specific anti-immunoglobulin conjugated with 
alkaline phosphatase, according to a technique developed by J. F. Kearney (personal 
communication). 
Mapping Studies  and Strain  Distribution.  Because,  as  will  be shown  below,  the  two 
monoclonal  antibodies  react  with  T-cell  antigens  governed  by the  Qa/Tla  region, 
these  antigens  have  been  designated  Qat-4  and  Qat-5.  In  Table  I,  the  reactivity 
patterns obtained with some inbred strains are listed. It can be seen that monoclonal 
antibodies B16-146  (anti-Qat-4)  and B16-167  (anti-Qat-5)  react with splenocytes of 
C57BL/6 and B10 mice but fail to lyse cells from congenic B10.BR mice. These data 
indicate linkage of the respective genes to the MHC. Typing of intra H-2 recombinant 
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TABLE  I 
Strain Distribution and Linkage to the H-2 Complex of Antigens Identified by Monoclonal T Antibodies, 
B16-146 (Anti-Qat-4)  and B16-167 (Anti-Qat-5) 
Strain 
H-2 complex  Titer* of antibody~: 
K  I  D  TL  Anti-Qat-4  Anti-Qat-5 
C57BL/6, B10  b  b  b  b  10  -n  10  -4 
B10.BR  k  k  k  a  <1  <1 
B10.A (2R)  k  k/d  b  h  10  -6  10  -3 
B10.A (4R)  k  k/b  b  b  10  -8  10  -4 
B10.A (5R)  b  k/d  d  a  10  -a  <l 
B10.HTT  s  s/k  d  c  10  -3  <1 
B10.D2  d  d  d  e  10  -4  10 
B10.A  k  k/d  d  a  10  -a  <1 
A.BY  b  b  b  b  10  -8  10-a-10  -4 
C3H.SW  b  b  b  c  10  -8  10-4 
SJL  s  s  s  a  10  -3  10 
BALB/c  d  d  d  c  < 1  < 1 
AKR, CBA  k  k  k  b  <1  <1 
* Average reciprocal 50% titer against lymph node cells obtained in several independent microcytotoxicity 
experiments~ 
:~ Ascites  fluids were used of either AKD2 mice injected with hybridoma B 16-146 or of NMRI nude mice 
injected with B 16-167 hybridoma cells. 
B10.A(2R)  and  B10.A(4R), suggesting linkage of the respective genes to the D  end of 
the H-2 complex.  Strains carrying the H-2D d allele (B 10.D2,  B 10.A, B 10.HTT)  react 
with both antibodies at a  much  lower titer indicating that H-2 d and H-2 b haplotypes 
may  be associated with different allelic forms of the new antigens. 
To locate more precisely the genes for Q at-4 and Qat-5 several H-2/Tla recombinant 
strains  were  investigated.  The  respective  gene  charts  and  the  rest~lts  obtained  are 
depicted  in Fig.  2. The  position of Qa-1 (the only other gene marker  in the TL  region) 
and  the Qa-1  phenotypes  of B6.K1  and  B6.K2 are presently in doubt  (14)  and  hence 
a  more  precise  location  of  Qat-4  and  Qat-5  loci  are  not  possible.  In  spite  of  this 
complication,  the  positive  reaction  of both  monoclonal  antibodies  with  B6.K2  cells 
and  the absence  of reactivity  with  B6.K1  cells allows  a  tentative  assignment  of the 
respective genes to the Qa-2,3 region. Because of the close linkage to the Qa/Tla region 
we have provisionally designated  the new loci Qat-4 and  Qat-5. G. J.  H.g,  MMERLING, U. HAMMERLING, AND L. FLAHERTY 
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FIG. 2.  Reactivity of monoclonal anti-Qat-4 and anti-Qat-5 with Tla recombinant strains. The 
position of Qa-I and the Qa-1 phenotypes  of B6.KI and B6.K2 are presently  in doubt (15). 
During the course of the mapping studies it was surprising to find that neither A/ 
Boy nor A.Tla  b strains reacted with anti-Qat-4  and  anti-Qat-5  although both A/J 
and C57BL/6 were positive. C57BL/6 has been thought to have provided the Qa/Tla 
region of the A-tla b recombinant.  Possible explanations for this observation will be 
discussed below. 
Table II summarizes the results of an extensive strain distribution analysis. Two 
cytotoxicity procedures were  used  in  parallel.  In  the  first,  cytolysis was  scored by 
trypan blue exclusion, and in the other by Cr  51 release. In most cases strains typing 
positively for anti-Qat-4 are also positive for anti-Qat-5, exceptions were strains A/ 
HeJ and A/J, which reacted with the former, but not the latter antibody. In view of 
the generally much weaker reactions of the anti-Qat-5 antibody it is possible that the 
assay  failed  to  reveal  a  weak  cross-reactivity.  No  strain  has  been  found which  is 
positive for Qat-5 and negative for Qat-4. 
Selective Reactivity  of Monoclonal Anti-Qat-4 and Anti-Qat-5 with Peripheral  T-Cell Popu- 
lations.  In  view  of  the  observations  that  anti-Qat-4  and  anti-Qat-5  lyse  only  a 
proportion of spleen cells (50 and 30%, respectively; see Fig.  1) and because of linkage 
of the respective genes to the Q.a region, T  cells were strongly implicated. An analysis 
was undertaken to verify whether the respective antigens were expressed on either T 
cells or B cells, or both. The results have confirmed the selective expression on T  cells. 
As summarized in Table III, thymocytes and anti-Thy-l.2-treated spleen cells (>95% 
Ia  +) did not react with either antibody, whereas nylon-purified T  cells (12) and anti- 
Ig-treated  spleen  cells  (13)  (>90%  Thy-l.2  +)  reacted  strongly.  Anti-Q.at-5  killed 
consistently 35% of peripheral T  cells, and anti-Qat-4 was cytolytic for 75% of T  cells, 
with a titer of 10  -6. Thus, both antibodies define two T-cell-associated differentiation 
antigens  which  are expressed by distinct  subpopulations  within  peripheral  T  cells. 112  NEW MURINE T-CELL ALLOANTIGENS, Qat-4 AND Qat-5 
TABLE II 
Strain Distribution* of Qat-4 and Qat-5 
Group I 
High titered reaction~ 
(Qat-4  ÷ Qat-5  +) 
B10, C57BL/6,  B10.A(2R), B10.A(4R), B6.K2, B6-TIa a, A.BY, 
C3H.SW, BALB.B, 129, C58, C57L, A.SW 
Group II 
Medium titer§ 
(Qat-4  ÷ Qat-5-) 
B10.D2, BI0.A(5R),  B10.HTT,  A/J, A/Hej, A/WySn, A.TL, 
A.TH, SJL, DBA/2 
Group III 
Negative 
(Qat-4- Qat-5-) 
B10.BR, B6.K1, B6-H-2  k, AKR, CBA/J CBA/HN, C3H/An, 
C57BR/cdJ,  BALB/cBy,  A.CA,  SEC/1,  P/J,  BDP,  BUB, 
SWR 
* Cytotoxicity obtained with ascites fluids and rabbit complement  was determined by trypan blue and 
~lCr release. 
:~ Higher titer: -10  -6 for anti-Qat-4,  ~10  -3 for anti-Qat-5. 
§ Medium titer: ~10  -n for anti-Qat-4 and very weak or negative for anti-Qat-5. 
TABLE III 
Selective Reactivity of Antibodies Anti-Qat-4 and Anti-Qat-5 with Peripheral T Cells  from C57BL/6 
Mice 
Monoclonal antibody*  Specificity 
Lysis of::]: 
Spleen  T cells  B cells  Thymo- 
cytes 
% 
6/68  Thy- 1.2  50  >95  0  >98 
B 1%263  Ia.8  60  0  >95  0 
B 16-146  Qat-4  55  75  0  0 
B16-167  Qat-5  25  35  0  0 
* Antibody 6/68 is a monoclonal anti-Thy-1.2  antibody (10). Antibody B17-263 is a monoclonal AKR 
anti-C57BL/6  antibody with specificity for Ia.8 (G. Hfimmerling and H. Lemke, unpublished  observa- 
tions). 
:]: T cells were obtained by removal of splenic B cells on rabbit anti-mouse Ig-coated plastic dishes (13). B 
cells were obtained by treatment of spleen cells with antibody 6/68 (anti-Thy-1.2) plus complement. The 
average percent lysis determined by several independent  microcytotoxicity assays is presented. 
Among other tissues, brain, liver, kidney, and erythrocytes were found to be negative 
as indicated by their inability to absorb the anti-Qat antibodies (data not shown). 
Reactivity  with  Cells  from Nude  Mice.  In  the course of an  analysis of spleen cells of 
C57BL/6  nu/nu  mice as a  source of B  lymphocytes, it has been found that anti-Qat- 
4 antibody (but not anti-Qat-5) reacted with a small proportion of cells (see Fig. 3 A). 
After removal of immunoglobulin-bearing cells (13)  from nude spleen the anti-Qat-4- 
positive cells could be shown to belong to the pool of Ig-negative cells some of which 
were  also Thy-l.2 positive and  may  therefore constitute T  cells  (see Fig.  3B).  The 
failure of anti-Qat-5 to react with C57BL/6 nu/nu spleen cells may again be explained 
on  the basis of the generally weaker cytolytic titer of this antibody as compared to 
anti-Qat-4. Even this powerful antibody had a  titer of only  10 -3 on C57BL/6  nu/nu 
target cells, which may point to a  low epitope density of Q.at-4 determinants on nude 
spleen cells, as opposed to normal T  cells. G. J.  H,~MMERLING, U.  H,g,  MMERLING,  AND  L.  FLAHERTY 
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FIG. 3.  Expression of Qat-4 and Qat-5 on Ig-negative nude spleen cells. (A) Reactivity of ascites 
fluids of anti-Qat-4 and anti-Qat-5 with unseparated splenocytes from  C57BL/6 nu/nu spleens. 
The anti-Thy-  1.2 antibody is derived from culture supernates ofhybridoma 6/68 (10). (B) Reactivity 
with C57BL/6 nu/nu spleen cells depleted of Ig-positive cells by fractionation over anti-Ig-coated 
plastic dishes (13). 
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FIG. 4.  Fluorescence  activated  cell  sorter  analysis of  profiles  Qat-4  and  Qat-5  antigens  in 
C57BL/6 lymph node T cells. T cells were obtained by passage of C57BL/6 lymph node cells over 
anti-Ig-coated plastic dishes. Indirect fluorescence staining was performed as described in Materials 
and Methods with ascites fluid at a 1:50 dilution with the exception of the anti-Lyt-2.2 antibody for 
which undiluted culture supernate of hybridoma 19/178 was used. The anti-Thy-1.2 antibody was 
obtained from NMRI nu/nu mice bearing the Thy-1.2 specific hybridoma 6/68 (10) in aseites form, 
while the negative control consisted of ascites fluid from BALB/c mice bearing the plasmacytoma 
P3-X63-AgS. 
Fluorescence Profile  of  T  Cells Reactive with  Anti-Qat-4  and  Anti-Qat-5.  Additional 
information on  the  reactivity pattern  of anti-Qat-4  and  anti-Qat-5  was  obtained 
through analysis by a fluorescence-activated cell sorter (FACS). B cells were depleted 
from C57BL/6 lymph node cells by adherence to rabbit anti-mouse-Ig-coated dishes 
(13),  and  the  resulting purified T  cells were  reacted  with  ascites  fluids at  a  1:50 
dilution, and after washing, with fluorescein-conjugated rabbit anti-mouse Ig. As a 
negative control a  1:50 dilution of ascites fluid of BALB/c mice bearing the plasma- 
cytoma P3-X63-Ag8  was  used, although positive controls consisted of monoclonal 
anti-Thy-l.2  of clone  5/68,  which  like  anti-Qat-4  and  anti-Qat-5  belongs  to  the 
kappa/# class (10). Another positive control was culture supernate from monoclonal 
anti-Ly-2.2 antibody hybridoma  19/178  (kappa,  IgG2A)  (U.  H/immerling, unpub- 
lished observations). The fluorescence profiles of Qat-4 obtained with the FACS (see 
Fig. 4)  display a  distinct shoulder which comprised 68.5%  of peripheral T  cells.  For 
Qat-5 the number of positive cells was calculated to be 29.2% above the background 
control with P3-X63-Ag8 antibody. However, no distinct peak or shoulder was found 114  NEW  MURINE T-CELL ALLOANTIGENS,  Qat-4  AND  Qat-5 
(see Fig. 4A). The cells displaying a continuum of weakly positive to negative, made 
the  exact  determination  of positive cells somewhat  ambiguous.  However, because 
cytotoxicity  analysis and FACS analysis were in close agreement for practical purposes, 
a distribution of 70% for Qat-4 and 30% of Qat-5 within the peripheral T  population 
may be sufficient. For comparison, the fluorescence profiles of the same T cells stained 
with  monoclonal  anti-Ly-2.2  and  anti-Thy-l.2  are  also  presented  (see  Fig.  4B). 
Staining with anti-Ly-2.2 results in a sharp peak comprising T  cells, whereas staining 
with anti-Thy-l.2 covers a wide range from dim to very bright cells. Although these 
data do not allow firm calculations of the number of antigenic determinants per cell, 
it can be estimated that on the average, T  cells express several times more Thy-l.2 
antigens than Qat-4 and Qat-5 determinants. 
Discussion 
The availability of techniques to produce monoclonal antibodies against  specific 
alloantigenic determinants provided us with the opportunity to search for antibodies 
against  new cell surface structures in immunizations between noncongenic partner 
strains such as AKR anti-C57BL/6. Of the several monoclonal antibodies produced 
in this immunization, two, B16-146 and B16-167, appear to recognize new antigenic 
determinants governed by the Qa region. Because these new antigens are selectively 
expressed on  subpopulations  of peripheral T  lymphocytes, they were provisionally 
designated Qat-4 and Qat-5, respectively. The loci (or locus) governing the expression 
of these antigenic determinants were located on the basis of serological studies of H-2 
and  Tla region recombinants and congenic strains. The more salient features of this 
analysis are given below: 
(a)  The  strain  distribution  of Qat-4  and  Qat-5  according to  direct  cytotoxicity 
assays on nylon column purified cells and  lymph node lymphocytes indicates that 
Qat-4 and Qat-5 expression are governed by genetic loci on chromosome 17 which 
are different from H-2, la, and Tla. 
(b)  Reactivity of these antisera against  B6.K2 cells and not B6.K1 cells indicates 
that  the locus or loci governing Qat-4  and  Qat-5  are near Qa-2  and  Qa-3 but  not 
identical to these loci on the basis of tissue distributions (see below) and on the basis 
of strain distributions (Table II). 
(c)  The expression of Qat-4 and Qat-5 seems to depend on the expression of Qa-2. 
All strains which are Qa-2- are also Qat-4- and Qat-5-, whereas Qa-2 + strains can 
either be Qat-4  + Qat-5 +, Qat-4  ÷ Qat-5-, or Qat-4- Qat-5-. No Qat-4- Qat-5 + strain 
has yet been detected. 
(d)  Qat-4  + strains which possess the H-2D d allele react to anti-Qat-4 with a much 
lower titer in the direct cytotoxicity test than H-2D b strains, suggesting that H-2D d 
strains may bear slightly different Qat-4 antigens than H-2D b strains (Table I). 
Studies on the tissue distribution show clearly that among lymphocytes, Qat-4 and 
Qat-5 antigens are restricted to peripheral T  lymphocytes on which they occur in a 
lower density than Thy- 1 determinants, as indicated by fluorescence studies. They are 
absent from thymocytes, suggesting that  immature, Qat-4 negative thymocytes dif- 
ferentiate into Qat-4 positive T cells. However, Qat-4 antigen is also present, albeit in 
a low density, on Ig-negative lymphocytes from nude mice, indicating that these cells 
can acquire a T-cell differentiation marker in the absence of a thymic environment. 
Similar observations have been reported by Loor and Roelants  (15)  with regard to G. J.  Hfi.MMERLING,  U.  H.~MMERLING,  AND L. FLAHERTY  115 
the expression of Thy-1.2 on spleen cells in nude mice. 
It is not clear whether Qat-4 and Qat-5  antigens are identical with or different 
from any of the known antigens specified by the Tla region. Of these, TL, Qa-1, and 
Qa-2 can be excluded because these antigens are expressed on thymocytes which lack 
Qat-4 and Qat-5. In contrast, Qa-3, Qat-4, and Qat-5 antigens appear to be similar 
with regard to their restricted expression on peripheral T  cells.  However, the strain 
distributions of known Qa-3 alleles (14) and of Qat-4 and Qat-5 are not completely 
identical. Qa-3  can be found on BALB/cJ cells  (5)  which are unreactive with our 
monoclonal antibodies.  Qa  antigens defined with conventional antisera, may still 
represent  complex systems and may include Qat-4 and Qat-5  antigens. Obviously, 
highly specific monoclonal antibodies to Qa antigens and TL being developed in our 
laboratories will be more suitable reagents for the definition of antigenic determinants 
encoded by the Tla region. 
The observation that  the two monoclonal antibodies react with a  different per- 
centage of T  lymphocytes (70 and 30%, respectively) does not necessarily distinguish 
the Qat-4  and  Qat-5  antigens as  two different antigens.  They may represent  two 
different ar~tigenic determinants on the same molecule. However, if this were the case 
then one has to assume that the two determinants are located far apart on the Qat 
molecule because the binding of radioiodinated anti-Qat-5 to T  cells could only be 
inhibited by preincubation with cold anti-Qat-5 but not by cold anti-Qat-4 (unpub- 
lished data). 
Depletion of lymphocyte subpopulations with anti-Qat sera should reveal if these 
antibodies can be used for the definition of functional T-cell populations. Preliminary 
studies indicate that treatment of T  helper cells with either anti-Qat-4 or anti-Qat-5 
and complement had no effect on helper activity for antibody formation, whereas 
with anti-Qat-5 an increase in helper activity was frequently observed, suggesting the 
removal of regulatory T  cells by this antibody. 
Summary 
Two  new lymphocyte antigens,  provisionally designated Qat-4  and  Qat-5  have 
been  identified  with  two  different  hybridoma-derived,  monoclonal  AKR  anti- 
C57BL/6  antibodies.  These  antigens  are  governed  by  genes  located  to  the  right 
(distal) end of the H-2 complex, within the Qa-2,3 region. Qat-4 and Qat-5 antigens 
which do not seem to be identical with Qa-2,3 or TL antigens are absent from Ig  + 
lymphocytes and thymocytes. They are only present on a  fraction of peripheral  T 
cells. Thus, Qat-4 is expressed on 70%, and Qat-5 on 30% of splenic and lymph node 
T  cells, Qat-4  is  also found on the majority of Ig- cells from athymic nude mice. 
These findings illustrate the complexity of the chromosome segment between the H- 
2D and  Tla  loci and they emphasize the role of major histocompatibility complex- 
associated genes for the differentiation of T  ceils into different subpopulations with 
possibly distinct immunologic functions. 
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